{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:22:19Z","timestamp":1783027339686,"version":"3.54.6"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021071","name":"The University of Sydney Faculty of Medicine and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cancer Policy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jcpo.2026.100740","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:53:09Z","timestamp":1776027189000},"page":"100740","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The emerging burden of triple-negative breast cancer in Australia: Universal care does not guarantee equitable access"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-5353","authenticated-orcid":false,"given":"Nasrin","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kin","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashidul Alam","family":"Mahumud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jcpo.2026.100740_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","article-title":"Treatment landscape of triple-negative breast cancer\u2014expanded options, evolving needs","volume":"19","author":"Bianchini","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"15","key":"10.1016\/j.jcpo.2026.100740_bib2","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.3390\/cancers13153697","article-title":"Triple-negative breast cancer: a mountain yet to be scaled despite the triumphs","volume":"13","author":"Wu","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.jcpo.2026.100740_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/BCTT.S236483","article-title":"Effect of clinical and treatment factors on wsurvival outcomes of triple-negative breast cancer patients","volume":"12","author":"Wen","year":"2020","journal-title":"Breast Cancer Targets Therapy"},{"key":"10.1016\/j.jcpo.2026.100740_bib4","unstructured":"National Breast Cancer Foundation (Australia). Uncovering new indicators and treatments for triple-negative breast cancer metastasis [Internet]. Sydney (NSW): National Breast Cancer Foundation; 30 Apr 2024 [cited 2026 Jan 23]. Available from: \u3008https:\/\/nbcf.org.au\/project\/uncovering-new-indicators-and-treatments-for-triple-negative-breast-cancer-metastasis\/?utm_source=chatgpt.com\u3009."},{"key":"10.1016\/j.jcpo.2026.100740_bib5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2147\/BCTT.S516125","article-title":"Triple-negative breast cancer on the rise: breakthroughs and beyond","volume":"17","author":"Agelidis","year":"2025","journal-title":"Breast Cancer Targets Therapy"},{"key":"10.1016\/j.jcpo.2026.100740_bib6","unstructured":"Australian Government Department of Health and Aged Care. Medicare and the Pharmaceutical Benefits Scheme: ensuring universal access to medicines and care. Canberra: Commonwealth of Australia; current edition."},{"key":"10.1016\/j.jcpo.2026.100740_bib7","series-title":"Health Systems Financing: the Path to Universal Coverage","author":"Etienne","year":"2010"},{"issue":"1","key":"10.1016\/j.jcpo.2026.100740_bib8","first-page":"29","article-title":"Disparities in breast cancer survival for Indigenous Australian women","volume":"214","author":"Dasgupta","year":"2021","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.jcpo.2026.100740_bib9","article-title":"Improving cancer outcomes for Aboriginal Australians through culturally safe care","volume":"32","author":"Garvey","year":"2023","journal-title":"Lancet Reg. Health West. Pac."},{"issue":"9","key":"10.1016\/j.jcpo.2026.100740_bib10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.jcpo.2026.100740_bib11","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","article-title":"Overall survival with pembrolizumab in early-stage triple-negative breast cancer","volume":"391","author":"Schmid","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jcpo.2026.100740_bib12","series-title":"Public Summary Document: Pembrolizumab (Keytruda\u00ae) for High-risk Early-stage Triple-negative Breast Cancer","author":"Pharmaceutical Benefits Advisory Committee (PBAC)","year":"2023"},{"key":"10.1016\/j.jcpo.2026.100740_bib13","first-page":"39","article-title":"Socioeconomic disparities in breast cancer care: addressing global challenges in oncology outcomes","volume":"14","author":"Opia","year":"2025","journal-title":"Int. J. Comput. Appl. Technol. Res."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100740_bib14","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5694\/mja2.52367","article-title":"Out-of-pocket health care expenses for people with and without cancer, New South Wales, Australia","volume":"221","author":"Goldsbury","year":"2024","journal-title":"Med. J. Aust."},{"issue":"2","key":"10.1016\/j.jcpo.2026.100740_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55388","article-title":"Financial toxicity among patients with breast cancer worldwide: a systematic review and meta-analysis","volume":"6","author":"Ehsan","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jcpo.2026.100740_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103813","article-title":"Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtype","volume":"78","author":"Smith","year":"2024","journal-title":"Breast"},{"issue":"12","key":"10.1016\/j.jcpo.2026.100740_bib17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/djac173","article-title":"Housing and cancer care and outcomes: a systematic review","volume":"114","author":"Fan","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jcpo.2026.100740_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1338754","article-title":"Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia-a population-wide epidemiological study of linked cancer registry and treatment data","volume":"14","author":"Morrell","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jcpo.2026.100740_bib19","unstructured":"Cancer Australia. National Cancer Data Framework. Canberra: Australian Government; 2025. Available from: https:\/\/www.canceraustralia.gov.au\/publications-and-resources\/cancer-australia-publications\/national-cancer-data-framework."}],"container-title":["Journal of Cancer Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221353832600041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221353832600041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:48:23Z","timestamp":1783025303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221353832600041X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":19,"alternative-id":["S221353832600041X"],"URL":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100740","relation":{},"ISSN":["2213-5383"],"issn-type":[{"value":"2213-5383","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The emerging burden of triple-negative breast cancer in Australia: Universal care does not guarantee equitable access","name":"articletitle","label":"Article Title"},{"value":"Journal of Cancer Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcpo.2026.100740","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100740"}}